Bausch + Lomb Corporation (TSX:BLCO)
27.94
-0.81 (-2.82%)
Oct 30, 2026, 3:51 PM EDT
Bausch + Lomb Revenue
In the year 2025, Bausch + Lomb had annual revenue of $5.10B USD with 6.47% growth. Bausch + Lomb had revenue of $1.38B in the quarter ending September 30, 2026, with 7.34% growth.
Revenue
$5.10B
Revenue Growth
+6.47%
P/S Ratio
1.30
Revenue / Employee
$392.38K
Employees
13,000
Market Cap
9.98B CAD
Revenue by Segment
Fiscal year ended Dec 31, 2025 See the full Bausch + Lomb breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 5.10B | 310.00M | 6.47% |
| Dec 31, 2024 | 4.79B | 645.00M | 15.56% |
| Dec 31, 2023 | 4.15B | 378.00M | 10.03% |
| Dec 31, 2022 | 3.77B | 3.00M | 0.08% |
| Dec 31, 2021 | 3.77B | 353.00M | 10.35% |
| Dec 31, 2020 | 3.41B | -366.00M | -9.69% |
| Dec 31, 2019 | 3.78B | 113.00M | 3.08% |
| Dec 31, 2018 | 3.67B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Apotex Health | 3.20B |
| Extendicare | 1.98B |
| Curaleaf Holdings | 1.87B |
| Green Thumb Industries | 1.72B |
| WELL Health Technologies | 1.52B |
| Sienna Senior Living | 1.08B |
| Knight Therapeutics | 547.31M |
| DRI Healthcare Trust | 285.04M |
Bausch + Lomb News
- 1 day ago - Bausch + Lomb price target raised to $20 from $16 at Deutsche Bank - TheFly
- 1 day ago - Bausch + Lomb price target raised to $22 from $16 at JPMorgan - TheFly
- 2 days ago - Bausch + Lomb announces publication of results from survey on dry eye symptoms - TheFly
- 2 days ago - Bausch + Lomb price target raised to $23 from $21 at Citi - TheFly
- 2 days ago - Bausch + Lomb Announces Publication of Multinational Survey Results Highlighting the Burden of Dry Eye Symptoms and Opportunities for Improved Awareness and Patient Education - Business Wire
- 3 days ago - Bausch + Lomb Earnings Call Transcript: Q3 2026 - Transcripts
- 3 days ago - Bausch + Lomb Slides: Q3 2026 - Filings
- 3 days ago - Bausch + Lomb Earnings release: Q3 2026 - Filings